Abstract:Beibei Hu, 1, 2 Jianxin Wang, 3 Jing Li, 3 Sanming Li, 3 Heran Li 1 1 School of Pharmacy, China Medical University, Shenyang 110122, People's Republic of China; 2 College of Chemistry and Pharmaceutical Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, People's Republic of China; 3 School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, People's Republic of China Correspondence: Heran Li School of Pharmacy, China Medical University, 77 Puhe Road, Shenyang North New Area, Shenyang 110122, People's Republic of China Tel +86 13897945866 Email liheranmm@163.com Purpose: The purpose of this research was to study the basic physicochemical and biological properties regarding the application of L-tartaric acid modified chiral mesoporous silica nanoparticle (CMSN) as a drug carrier, and to explore the structure–property relationship of silica-based materials. Methods: CMSN with functions of carboxyl modification and chirality was successfully synthesized through co-condensation method, and the basic characteristics of CMSN, including morphology, structure, wettability, degradation, bio-adhesion and retention ability in gastrointestinal tract (GI tract) were estimated by comparing with non-functionalized mesoporous silica nanoparticles (MSN). Meanwhile, the biocompatibility and toxicity of L-tartaric modification were systematically evaluated both in vitro and in vivo through MTT cell viability assay, cell cycle and apoptosis assay, hemolysis assay, histopathology examination, hematology analysis, and clinical chemistry examination. Results: CMSN and MSN were spherical nanoparticles with uniform mesoporous structure. CMSN with smaller pore size and carboxyl functional groups exhibited better wettability. Besides, CMSN and MSN could dissolve thoroughly in simulated physiological fluids during a degradation period of 1– 12 weeks. Interestingly, the in vitro and in vivo behaviors of carriers, including degradation, bio-adhesion and retention ability in the GI tract were closely related to wettability. As expected, CMSN had faster degradation rate, higher mucosa-adhesion ability, and longer retention time. Particularly, CMSN improved the bio-adhesion property in both gastric mucosa and small intestinal mucosa, and prolonged the GI tract retention time to at least 12 h, which meant higher probability for absorption. The biocompatibility and toxicity examination indicated that CMSN was a kind of biocompatible bio-material with good blood compatibility and negligible toxicity, which is required for further applications in biological fields. Conclusion: CMSN with functions of carboxyl modification and chirality had superiority in terms of both physicochemical and biological properties. The in vitro and in vivo behaviors of carriers, including degradation, bio-adhesion, and retention were closely related to wettability. Keywords: chiral mesoporous silica, carboxyl modification, wettability, bio-adhesion, biocompatibility

Alanine modified chiral-responsive mesoporous silica as nanocarriers for improved oral bioavailability of carvedilol

Enantioselective Oral Absorption of Molecular Chiral Mesoporous Silica Nanoparticles

Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility

Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.

Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect

Chiral mesoporous silica nano-screws as an efficient biomimetic oral drug delivery platform through multiple topological mechanisms

Biomimetic aminoated mesoporous silica xerogel exhibiting chiral surface topology for delivery insoluble drug with multiple-controlled manners and improved oral adsorption

Multichiral Mesoporous Silica Screws with Chiral Differential Mucus Penetration and Mucosal Adhesion for Oral Drug Delivery

Synthesis, structural properties, biosafety and applications of chiral mesoporous silica nanostructures

Chiral microenvironment-responsive mesoporous silica nanoparticles for delivering indometacin with chiral recognition function

Mesoporous silica nanoparticles with chiral pattern topological structure function as "antiskid tires" on the intestinal mucosa to facilitate oral drugs delivery

Synthetic Design Towards Targeted Chiral Anionic Surfactant Templated Chiral Mesoporous Silica

Anionic surfactant templated chiral nanospheres and their enantioselective adsorption

Chiral Mesoporous Silica Materials: A Review on Synthetic Strategies and Applications

Candesartan Cilexetil Formulations in Mesoporous Silica: Preparation, Enhanced Dissolution In Vitro, and Oral Bioavailability In Vivo

Preparation and Evaluation of SBA-16, ZSM-5 and MCM-41 Mesoporous Silica Nanoparticles as Drug Delivery System for Carvedilol

Carboxymethyl Chitosan Coated Alpha-Linolenic Acid Nanoliposomes: Preparation, Stability and Release in Vitro and in Vivo.

Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment

Understanding the Mechanism of Chirality Transfer in the Formation of a Chiral MCM-41 Mesoporous Silica

Preparation and characterization of carvedilol solid dispersions using hollow mesoporous silica nanoparticles

Chiral Skeletons of Mesoporous Silica Nanospheres to Mitigate Alzheimer?s ?-Amyloid Aggregation